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The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway 
bacterial sampling in young children with cystic fibrosis: 
a prospective internally controlled interventional trial
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Summary
Background Pathogen surveillance is challenging but crucial in children with cystic fibrosis—who are often non-
productive of sputum even if actively coughing—because infection and lung disease begin early in life. The role of 
sputum induction as a diagnostic tool for infection has not previously been systematically addressed in young children 
with cystic fibrosis. We aimed to assess the pathogen yield from sputum induction compared with that from cough 
swab and single-lobe, two-lobe, and six-lobe bronchoalveolar lavage.
Methods This prospective internally controlled interventional trial was done at the Children’s Hospital for Wales 
(Cardiff, UK) in children with cystic fibrosis aged between 6 months and 18 years. Samples from cough swab, sputum 
induction, and single-lobe, two-lobe, and six-lobe bronchoalveolar lavage were matched for within-patient 
comparisons. Primary outcomes were comparative pathogen yield between sputum induction and cough swab for 
stage 1, and between sputum induction, and single-lobe, two-lobe, and six-lobe bronchoalveolar lavage for stage 2. 
Data were analysed as per protocol. This study is registered with the UK Clinical Research Network (14615) and with 
the International Standard Randomised Controlled Trial Network Registry (12473810).
Findings Between Jan 23, 2012, and July 4, 2017, 124 patients were prospectively recruited to the trial and had 
200 sputum induction procedures for stage 1. 167 (84%) procedures were successful and the procedure was well 
tolerated. Of the 167 paired samples, 63 (38%) sputum-induction samples were pathogen positive compared with 
24 (14%) cough swabs (p<0·0001; odds ratio [OR] 7·5; 95% CI 3·19–17·98). More pathogens were isolated from 
sputum induction than cough swab (79 [92%] of 86 vs 27 [31%] of 86; p<0·0001). For stage 2, 35 patients had a total of 
41 paired sputum-induction and bronchoalveolar lavage procedures. Of the 41 paired samples, 28 (68%) were positive 
for at least one of the concurrent samples. 39 pathogens were isolated. Sputum induction identified 27 (69%) of the 
39 pathogens, compared with 22 (56%; p=0·092; OR 3·3, 95% CI 0·91–12·11) on single-lobe, 28 (72%; p=1·0; OR 1·1, 
95% CI 0·41–3·15) on two-lobe, and 33 (85%; p=0·21; OR 2·2, 95% CI 0·76–6·33) on six-lobe bronchoalveolar lavage.
Interpretation Sputum induction is superior to cough swab for pathogen detection, is effective at sampling the lower 
airway, and is a credible surrogate for bronchoalveolar lavage in symptomatic children. A substantial number of 
bronchoscopies could be avoided if sputum induction is done first and pathogens are appropriately treated. Both 
sputum induction and six-lobe bronchoalveolar lavage provide independent, sizeable gains in pathogen detection 
compared with the current gold-standard two-lobe bronchoalveolar lavage. We propose that sputum induction and 
six-lobe bronchoalveolar lavage combined are used as standard of care for comprehensive lower airway pathogen 
detection in children with cystic fibrosis.
Funding Health and Care Research Wales—Academic Health Science Collaboration and Wellcome Trust Institutional 
Strategic Support Fund.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. Open Access article under the CC BY 4.0 license.
Introduction
Longitudinal surveillance studies using repeated 
bronchoalveolar lavage in children with cystic fibrosis 
have reported that 30% of these children have 
Pseudomonas aeruginosa detected in the first 6 years of 
life,1 and that infection with significant pathogens occurs 
in the first 2 years of life in 71% of children.2 Notably, 
early infection was identified as the major determinant 
of lung function deterioration by school age, suggesting 
that it is an important driver of lung inflammation and 
has a crucial contribution to the development of cystic 
fibrosis lung disease.2 Young children with cystic fibrosis 
are generally asymptomatic, cough free, and non-
productive of mucus. These children are often incapable 
of expectorating sputum even if actively coughing during 
an exacerbation. Effective sampling for lower airway 
microbiology is therefore problematic, yet remains 
crucial in this age group if infection is to be effectively 
treated or prevented, and the potential benefits of 
newborn screening properly realised.3 Cystic fibrosis 
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standards of care recommend doing regular oro-
pharyngeal cough swabs for bacterial surveillance in 
young non-expectorating children. However, oropha-
ryngeal cultures are a poor surrogate for cultures from 
lower airway samples taken at concurrent bronchoalveolar 
lavage.4
Bronchoalveolar lavage is considered to be the gold 
standard for sampling lower airway microbiology.5 
Although the international community is interested in 
bronchoalveolar lavage-based microbiology-surveillance 
programmes, little evidence supports recommendation of 
this invasive approach in routine cystic fibrosis care.6,7 
Bronchoalveolar lavage is generally reserved for children 
with cystic fibrosis who have not responded to appropriate 
or empirical antibiotic treatment and in whom 
oropharyngeal cultures do not offer an explanation for the 
persistence of symptoms. No consensus exists on 
methods for bronchoalveolar lavage, and practice varies. 
Guidelines for children with cystic fibrosis recommend 
two-lobe bronchoalveolar lavage taken as follows: 
three-aliquot bronchoalveolar lavage from the right-
middle lobe and a single-aliquot bronchoalveolar lavage 
from the lingular or the most affected lobe.5 A study 
published in 20118 showed comprehensive six-lobe 
bronchoalveolar lavage sampling to be safe, well tolerated, 
and superior to single-lobe9 or two-lobe5 bronchoalveolar 
lavage, suggesting that bacterial communities might be 
compartmentalised within the lung.
Clinically, young children with cystic fibrosis have wet 
bronchitic-type coughs during infection, suggesting the 
predominant focus of infection might be the large 
intrathoracic airways rather than the alveolar bed. The 
large intrathoracic airway compartment is not routinely 
sampled because it is largely bypassed by even the most 
Research in context
Evidence before this study
We initially did a comprehensive review of the use of sputum 
induction in children with cystic fibrosis on March 1–15, 2011. We 
searched PubMed for studies published between Jan 1, 1960, and 
Dec 31, 2010, and updated the search on Dec 6, 2014. We used 
the following keywords: “induced sputum”, “sputum induction”, 
“bronchoalveolar lavage”, “cough swab”, “oropharyngeal”, 
“children”, “child”, “infant” “childhood”, “young”, “cystic fibrosis”, 
“CF”, and “hypertonic saline”. Few adequately powered studies 
were found. Six studies assessed sputum induction in children 
with cystic fibrosis and these were generally in older children who 
could perform spirometry reliably. Taken together, these studies 
included 211 patients and reported a 92·5% success rate in 
obtaining a sputum sample. Four studies compared sputum 
induction with oropharyngeal samples in children with cystic 
fibrosis. The two larger studies identified additional organisms 
on sputum induction in 30% and 42% of cases, but these studies 
mainly recruited school-age children and teenagers, many of 
whom could spontaneously expectorate sputum. One small 
study compared sputum induction with bronchoalveolar lavage 
in ten children with cystic fibrosis. During the period of 
recruitment to the present study, one study was published that 
showed sputum induction to be superior to oropharyngeal 
sampling in 32 children younger than 5 years, with an 
approximately two-fold increase in pathogen detection. A 
further single study compared sputum induction to gold-
standard two-lobe bronchoalveolar lavage in children, but paired 
samples were not necessarily taken at the same visit. That study 
found sputum induction sensitivity to be 37% and specificity to 
be 69%, compared with gold-standard two-lobe bronchoalveolar 
lavage, but discounted any pathogens isolated exclusively on 
sputum induction as false negatives.
Added value of the study
To our knowledge, this is the first time a study has compared 
concomitant cough swab, sputum induction, and the 
gold-standard two-lobe bronchoalveolar lavage to 
comprehensive six-lobe bronchoalveolar lavage to 
systematically define the relative contribution of each 
approach. Our data establish sputum induction as superior to 
cough swab and as a credible approach to sampling the lower 
airway in symptomatic children with cystic fibrosis when 
compared with bronchoalveolar lavage. This study shows that 
both sputum induction and six-lobe bronchoalveolar lavage 
contribute independent, sizeable gains in pathogen detection 
over and above two-lobe bronchoalveolar lavage, and 
challenges two-lobe bronchoalveolar lavage as an adequate 
gold-standard approach to understanding lower airway 
microbiology. Sputum induction is uniquely placed to sample 
the large intrathoracic airways, a compartment inadequately 
considered in the current paradigm of lower airway sampling. 
In symptomatic patients, doing sputum induction before 
bronchoalveolar lavage will correctly describe the lower airway 
pathogen environment in most patients, thereby markedly 
reducing the number of bronchoscopy procedures required.
Implications of all available evidence
Our study supports the recommendation that sputum 
induction and six-lobe lavage should be done together as a 
new standard of care for comprehensive assessment of the 
lower airway pathogen environment in children with cystic 
fibrosis. If sputum induction is done before bronchoalveolar 
lavage, a substantial number of bronchoscopies could be 
avoided in symptomatic children with cystic fibrosis. The 
inclusion of sputum induction as a regular contribution to 
cystic fibrosis care in children is supported by the tolerability 
of the procedure in all age groups, the ease of repeatability, 
the acceptability to parents and patients, the high success 
rates, the additional pathogens identified, and the clear 
economic savings. 
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extensive approach to bronchoalveolar lavage. Sputum 
induction is a safe approach to obtaining lower airway 
samples from patients who are not spontaneously 
productive10,11 and its use in tuberculosis surveillance in 
children is well established. The role of sputum induction 
in the care of young children with cystic fibrosis has not 
been systematically addressed and few studies exist.12–16 
Sample size and patient age have been variable in these 
studies but for the most part, conclusions have been 
encouraging. This trial (the Cystic Fibrosis Sputum 
Induction Trial [CF-SpIT]) takes a systematic approach to 
comprehen sively investigate and compare bacterial 
sampling techniques in young children with cystic 
fibrosis.
We aimed to test sputum induction as an infection 
diagnostic for bacterial sampling in children with cystic 
fibrosis compared with concurrent standard cough swab, 
single-lobe bronchoalveolar lavage, the gold-standard 
two-lobe bronchoalveolar lavage, and also comprehensive 
six-lobe bronchoalveolar lavage.
Methods
Study design and participants
Cf-SpIT is a prospective internally controlled inter-
ventional single-centre trial done at the Children’s 
Hospital for Wales (Cardiff, UK) in children with cystic 
fibrosis, comparing sputum induction, as a diagnostic 
intervention for pathogen detection, with concurrent 
cough swab, single-lobe bronchoalveolar lavage, gold-
standard two-lobe bronchoalveolar lavage, and 
comprehensive six-lobe bronchoalveolar lavage. The 
study was subject to Institutional Review by the Cardiff 
and Vale Research Review Service (CaRRS—Project 
ID 11-RPM-5216) and approved by the South Wales 
Research Ethics Committee (11/WA/0334).
We prospectively recruited children with cystic fibrosis 
aged between 6 months and 18 years, from the South, 
West and Mid-Wales Children’s Cystic Fibrosis Network. 
All children attending the Children’s Hospital for Wales 
for clinically indicated bronchoscopy, those attending for 
routine surgery under general anaesthetic, those 
admitted for treatment of a chest exacerbation, or those 
attending for annual review in the outpatient clinic were 
eligible. Children on treatment antibiotics at the time of 
sampling were excluded, to maximise the chances of 
successful bacterial culture.
The study was structured in two stages, each designed 
to test different hypotheses. In stage 1, sputum induction 
as a diagnostic intervention was tested against cough 
swab. Children were recruited for this stage of the study 
at any point when they would otherwise have a cough 
swab taken: in the outpatient clinic or as an inpatient 
before receiving intravenous antibiotics. In stage 2, 
sputum induction as a diagnostic intervention was tested 
against bronchoalveolar lavage. This was done in a 
subgroup of patients who had been recruited into stage 1, 
and who were also attending for a clinically indicated 
bronchoscopy and bronchoalveolar lavage. Specifically, 
sputum induction was compared to single-lobe 
bronchoalveolar lavage, two-lobe bronchoalveolar lavage, 
and six-lobe bronchoalveolar lavage.
Children could volunteer to take part on more than one 
occasion if the occasions were more than 3 months apart. 
Sputum induction was done immediately after cough 
swab and within the 24 h before bronchoscopy if paired 
with bronchoalveolar lavage. Children were classified as 
symptomatic at the time of recruitment if they had an 
increase in respiratory symptoms, defined as a wet or dry 
cough, wheeze, or coryzal symptoms. The cough was 
defined as wet if it sounded wet before the procedure. 
Data on pathogen isolates from the preceding 12 months 
before the procedure and new treatments commenced 
because of microbiology results from the procedure were 
recorded for all children.
Informed consent was taken by trained clinicians on 
the delegation log. Data for recruitment, clinical 
observations, and primary and secondary outcome 
measurements were collated by trained clinicians and 
research staff on the delegation log and managed by the 
chief investigator. Regular progress and safety reports 
were submitted to Research and Design and Ethics 
panels by the chief investigator.
Procedures
Sputum induction was done by a specialist physio-
therapist. 8 mL of 7% hypertonic sodium chloride 
solution was administered through a simple disposable 
oxygen-driven jet nebuliser set (SideStream disposable 
kit; Philips Respironics, Murrysville, PA, USA) at 
5 L/min for 15 min and physiotherapy was given during 
and after the nebuliser was completed. A combination of 
percussion, vibration, positive expiratory pressure, and 
active cycle of breathing compatible with the patient’s 
normal physiotherapy regimen was used. Oropharyngeal 
suction using a size 6, 8, or 10F suction catheter was used 
to obtain a sputum sample in children who could not 
spontaneously expectorate after the procedure. Duration 
of the procedure was limited to 30 min. Success of the 
procedure was defined as the ability to obtain a mucoid 
sample, per visual inspection. The physiotherapist 
documented heart rate, respiratory rate, and FEV1 where 
applicable before and after the procedure as objective 
measures of tolerance (appendix).
All bronchoscopy was done under general anaesthetic. 
Suction of secretions was avoided before bronchoalveolar 
lavage to preserve localised sampling without 
contamination. Samples were taken from all six lobes 
specifically in the following order: right middle lobe 
(RML), left lingular (LLi), right lower lobe (RLL), right 
upper lobe (RUL), left lower lobe (LLL), and left upper 
lobe (LUL). RML bronchoalveolar lavage was done using 
three aliquots of 1 mL/kg normal saline (maximum 
20 mL per aliquot) with low-level suction through the 
scope used to retrieve the sample between aliquots. 
For the Cf-SpIT study protocol 
see http://www.
cardiffandvaleuhb.wales.nhs.uk/
sitesplus/documents/1143/
Cystic%20Fibrosis%20Study.pdf
See Online for appendix
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A single aliquot of 1 mL/kg bodyweight (maximum 20 mL) 
was used for all other lobes. This aliquot was retrieved by 
light suction on the syringe used for instillation before 
the liquid column was broken. A second instillation of 
1 mL/kg (maximum 20 mL) was used for all lobes in 
which the initial aliquot did not return 40% volume or 
greater using syringe back-suction.
Bronchoalveolar lavage fluid from each individual was 
processed as three samples. All three aliquots from the 
RML were combined to form bronchoalveolar lavage 
sample 1. The single aliquot from the LLi was used as 
sample 2. Fluids from the remaining four lobes (RLL, RUL, 
LLL, and LUL) were combined to form sample 3. These 
three samples were sent to the microbiology lab where 
they were processed independently.
Because bronchoalveolar lavage samples 1, 2, and 
3 were taken in strict sequential order in all bronchoscopy 
procedures, we were able to combine the pathogens 
isolated to describe pathogen detection from increasingly 
extensive bronchoalveolar lavage. Pathogens isolated 
from sample 1 were used to describe pathogen detection 
from single-lobe bronchoalveolar lavage; pathogens 
isolated from samples 1 and 2 were combined to describe 
pathogen detection from two-lobe bronchoalveolar 
lavage; and pathogens isolated from samples 1, 2, and 
3 were combined to describe pathogen detection from 
six-lobe bronchoalveolar lavage.
Airway samples were processed using standard 
techniques for bacteria and fungi in the hospital 
laboratory of the University Hospital of Wales. The 
laboratory uses standards from the CF Trust Guidelines.17 
For all samples, Haemophilus influenzae, Staphylococcus 
aureus, meticillin-resistant S aureus (MRSA), P aeruginosa, 
Burkholderia cepacia complex species, non-tuberculous 
Mycobacterium species, Achromobacter xylosoxidans, 
Stenotrophomonas maltophilia, and Klebsiella pneumoniae 
were defined as cystic fibrosis airway pathogens.
All airway fluid samples were divided and one aliquot 
frozen at –80°C within 30 min of collection. Batch DNA 
extraction was done after a single freeze thaw, in an 
extraction-dedicated containment level 2 laboratory. 
Ribosomal intergenic spacer analysis (RISA) was done as 
described previously (appendix).18,19
Outcomes
The primary outcome was pathogen detection for all 
comparisons, measured by the proportion of patients 
with one or more positive samples (pathogen positive) 
and the number of pathogens isolated by each sampling 
approach. Secondary outcomes were success of sputum 
induction, proportion of cases in which sputum induction 
resulted in a change of treatment,  test-specific detection 
rates for all approaches against all pathogens isolated, 
and the sensitivity of each sampling approach to correctly 
identify all pathogens isolated from the lower airway.
Subjective tolerance was assessed using visual analogue 
Likert-type scales (score 1–10)20 completed by the parent 
or child, or both, and the physiotherapist who did the 
procedure.
Statistical analysis
We used discordant proportions to compute sample size. 
At the time of study initiation, no data were available on 
pathogen yield from sputum-induction sampling in 
children younger than 6 years with cystic fibrosis. Al-Saleh 
and colleagues13 studied sputum induction and throat 
swabs in 94 older children (mean age 12·1 years) with 
cystic fibrosis, most of whom could spontaneously 
expectorate. Discrepant culture results were seen in 
27% of paired samples. For stage 1, assuming sputum 
induction would be less successful in the younger age 
group who could not spontaneously expectorate, we 
powered the study to detect a smaller discrepancy of 
20% in culture results between cough swab and sputum 
induction. We used discordant proportions in keeping 
with the findings from Al-Saleh and colleagues13 
(27% discordance, odds ratio [OR] 8). Using these 
proportions, we calculated that a sample size of 59 pairs is 
capable of detecting 20% discordance in culture results 
with a power of 80% and probability of type I error of 0·05.
We planned subgroup analyses by age (<6 years or 
≥6 years) and symptom status (asymptomatic or 
symptomatic) for the stage 1 comparison of cough swab 
versus sputum induction. Assuming the same discordant 
proportions for all age groups, we required a sample size 
of 59 for each age subgroup. We therefore continued 
recruiting until at least 59 patients were recruited to each 
age subgroup, estimating that, taking patient withdrawals 
and exclusions into account, this would require 
prospective recruitment of 200 children in total.
No data comparing sputum induction with 
bronchoalveolar lavage were available at the time of study 
initiation. Therefore, for stage 2, we estimated discordant 
proportions to calculate the sample size. We estimated 
that a small proportion of pathogens (5%) would be 
isolated on sputum induction and not on bronchoalveolar 
lavage, and estimated discordance in culture results at 
34%. A sample size of 44 pairs would be able to detect a 
34% discrepancy between sputum induction and 
bronchoalveolar lavage with a power of 80% and 
type I error of 0·05.
We compared all paired proportions between sampling 
techniques using the two-sided McNemar’s test. We used 
binary logistic regression (BLR) to assess the effect of 
repeated measurements within the cohort on the success 
rate of sputum induction and on the rate of pathogen 
positivity of sputum induction. We used BLR to assess the 
effect of age, the presence of respiratory symptoms, the 
ability to expectorate spontaneously before the procedure, 
and the need for oropharyngeal suction during the 
procedure, on the number of pathogens detected by 
sputum induction, using generalised estimating 
equations (GEE)21 to account for correlation between 
repeated measurements in the same individual.
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We used test-specific detection rates when comparing 
different approaches to sampling, to interrogate the 
relative pathogen yield and help understand the relative 
sampling ability of each approach.
We generated a sensitivity analysis for each sampling 
approach against a combined gold standard consisting of 
all pathogens isolated from sputum induction and six-lobe 
bronchoalveolar lavage. A positive outcome was defined as 
the ability to identify all pathogens from the combined 
gold standard. This enabled us to quantify the ability of 
any single approach to correctly detect all lower airway 
pathogens in a given patient. We used BLR to assess the 
effect of age and the presence of respiratory symptoms on 
the ability of sputum induction to correctly detect all lower 
airway pathogens, using GEE21 to account for correlation 
between repeated measurements in the same individual. 
Statistical analyses were done using SPSS statistics for 
Windows, version 23.0. This study is registered with the 
UK Clinical Research Network (14615) and with the 
International Standard Randomised Controlled Trial 
Network Registry (12473810).
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. JTF, KR, and J-DT had access to the raw data. 
The corresponding author had full access to all of the 
data and the final responsibility to submit for publication.
Results
Between Jan 23, 2012, and July 4, 2017, 124 patients were 
prospectively recruited to the trial and had 200 sputum 
induction procedures (figure 1; table 1). Median time 
between procedures in patients that contributed more 
than one sample was 12 months (IQR 5·5–19). 72 (36%) 
of the 200 procedures were done in children younger 
than 6 years and 128 (64%) were done in children aged 
6 years or older. 128 (64%) of the samples came from 
children who were symptomatic at the time of sampling.
167 (84%) of 200 sputum-induction procedures were 
successful in producing a mucoid sputum sample. 
Repeated measures in those individuals recruited more 
than once did not affect the success of sputum induction 
(p=0·53). 22 (11%) of 200 children were able to 
expectorate sputum spontaneously before the sputum-
induction procedure. 87 (44%) of 200 children could 
expectorate sputum during the procedure without 
requiring suction. When analysed by age group, sputum 
induction was equally as successful in children younger 
than 6 years (62 [86%] of 72) as in those aged 6 years or 
older (105 [82%] of 128). Age as a continuous variable did 
not influence the success of the sputum-induction 
procedure (p=0·55). However, oral suction was required 
in 56 (90%) of 62 children younger than 6 years versus 
24 (23%) of 105 children aged 6 years or older. The 
sputum-induction procedure was similarly successful in 
the inpatient versus outpatient setting (100 [84%] of 
120 vs 67 [83%] of 80), in symptomatic versus 
asymptomatic children (110 [86%] of 128 vs 57 [79%] of 72), 
in those with a wet versus dry cough (59 [89%] of 66 vs 
108 [81%] of 134), and in patients who were naive to 
hypertonic saline versus those who were not 
(33 [89%] of 39 vs 134 [82%] of 169).
Of the 167 paired cough swab and sputum-induction 
samples, 63 (38%) sputum-induction samples were 
pathogen positive compared with 24 (14%) cough swabs 
(p<0·0001; OR 7·5; 95% CI 3·19–17·98). Repeated 
measures in individuals who gave more than one sample 
did not affect pathogen positivity in sputum-induction 
samples (p=0·99). An intention-to-treat analysis (ITT) in 
which unsuccessful sputum-induction attempts were 
classified as negative results remained significant 
(p<0·0001).
In subgroup analysis by age, in children younger than 
6 years, 18 (29%) of 62 sputum-induction samples were 
pathogen positive compared with eight (13%) of 
62 cough swabs (p=0·021; ITT analysis p=0·049). In 
children aged 6 years or older, 45 (43%) of 105 sputum-
induction samples were pathogen positive compared 
with 16 (15%) of 105 cough swabs (p<0·0001; 
ITT analysis p<0·0001). Age as a continuous variable 
was significant in predicting whether sputum would be 
pathogen positive (p=0·0028), whereas the ability to 
expectorate spontaneously before the procedure was not 
predictive (p=0·86). The ability to expectorate during 
Figure 1: Participant flow diagram
Patients could contribute a sample to the trial on more than one occasion if 
samples were taken at least 3 months apart.
35 patients had 41 bronchoscopy 
 and bronchoalveolar lavage 
 procedures
Stage 1 intention to treat
200 paired samples from 
 124 patients analysed
Stage 2 analysis
41 samples analysed
68 patients did not have 
 bronchoalveolar lavage
124 patients enrolled in whom 200 paired
cough swab and sputum-induction 
procedures were done
Stage 1 per protocol
167 paired samples from 103 patients analysed
33 sputum-induction 
 procedures were unsuccessful
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the procedure did not show an independent effect over 
age on whether sputum would be pathogen positive 
(p=0·24).
Sputum induction was more likely to be pathogen 
positive than cough swab in symptomatic children 
(46 [42%] of 110 vs 16 [15%] of 110; p<0·0001) and in 
asymptomatic children (17 [30%] of 57 sputum-
induction samples vs eight [14%] of 57 cough swabs; 
p=0·049). The likelihood of sputum induction being 
pathogen positive was not significantly affected by 
whether the child was symptomatic or asymptomatic 
(p=0·15).
86 pathogens were isolated from the 167 paired cough 
swab and sputum-induction samples (appendix). 
79 (92%) were isolated on sputum-induction samples 
and 27 (31%) were isolated on cough swabs (p<0·0001; 
figure 2A). Of the 86 pathogens isolated, 59 (69%) were 
identified by sputum induction only. More than one 
pathogen was identified on 13 (21%) of 63 positive 
sputum-induction samples. When analysed by age 
group, in children younger than 6 years, 20 (83%) of 
24 pathogens were isolated on sputum induction versus 
nine (38%) of 24 pathogens were isolated on cough swabs 
(p=0·019). In children aged 6 years or older, 59 (95%) of 
62 pathogens were isolated on sputum induction whereas 
18 (29%) of 62 on cough swab (p<0·0001). Sputum 
induction identified more of almost all the specific 
pathogens than cough swab (figure 2B).
The additional pathogen yield (any pathogen, 
previously detected or not) from sputum induction 
compared with paired cough swab resulted in a new 
treatment in 52 (31%) of 167 cases. When compared with 
all pathogens isolated on repeated cough swabs from the 
preceding 12 months (median number of cough swabs 
six; IQR 5–7), a previously undetected pathogen was 
isolated in 40 (24%) of 167 sputum samples versus 15 
(9%) of 167 cough swab samples (χ² p=0·00039). 
Treatment for a previously undetected pathogen isolated 
exclusively on sputum induction was commenced in 
32 (19%) of 167 cases.
41 of the 167 successful sputum induction and cough 
swab pairs from stage 1 were coupled with bronchoscopy 
and bronchoalveolar lavage for stage 2 (table 1). 35 patients 
contributed, of whom six individuals contributed twice 
(on two separate occasions). Median time between repeat 
procedures was 38 months (IQR 35–46). 32 (82%) of 
41 procedures were done in symptomatic patients. 
Additionally, eight bronchoscopies were done on 
asymptomatic patients with unexplained poor spirometry 
tests and one bronchoscopy was done in an asymptomatic 
patient at the end of treatment for non-tuberculous 
Mycobacteria infection. Median age was 8·5 years 
(IQR 6·5–12·6). Six-lobe bronchoscopy was tolerated well 
in all patients.
At least one pathogen was isolated from at least one of the 
concurrent samples in 28 (68%) of the 41 pairs. 39 different 
pathogens were isolated (table 2). Repeated measures in 
individuals recruited more than once did not affect 
pathogen positivity in either sputum-induction samples 
(p=0·94) or bronchoalveolar lavage samples (p=0·75).
Regarding pathogen yield from the different sampling 
techniques, sputum induction isolated 27 (69%) of the 
39 pathogens compared with 22 (56%; p=0·092; OR 3·3, 
95% CI 0·91–12·11) on single-lobe bronchoalveolar 
lavage, 28 (72%; p=1·0; OR 1·1, 95% CI 0·41–3·15) on 
two-lobe bronchoalveolar lavage, and 33 (85%; p=0·21; 
OR 2·2, 95% CI 0·76–6·33) on six-lobe bronchoalveolar 
lavage (figure 3A). Increasing numbers of pathogens 
were isolated on sequentially wider bronchoalveolar 
lavage sampling (χ² p=0·023).
The sputum-induction procedure identified 17 (77%) of 
22 of the pathogens present on single-lobe bronchoalveolar 
lavage, 20 (71%) of 28 on two-lobe bronchoalveolar lavage, 
and 22 (66%) of 33 on six-lobe bronchoalveolar lavage 
(figure 3B). Conversely, of the 27 pathogens present on 
sputum induction samples, single-lobe bronchoalveolar 
lavage isolated 17 (38%), two-lobe bronchoalveolar lavage 
isolated 20 (70%), and six-lobe bronchoalveolar lavage 
isolated 22 (80%).
For some specific pathogens, sputum induction 
outperformed six-lobe bronchoalveolar lavage (figure 3C). 
Five important pathogens (13% of total) were identified 
on sputum induction but not on six-lobe bronchoalveolar 
lavage (two P aeruginosa and one each of Burkholderia 
cepacia, Burkholderia cenocepacia, and MRSA). Because 
these pathogens were not isolated from paired cough 
swabs either, they are likely to be from the lower airway 
compartment.  
Test-specific detection rates were 69% for sputum 
induction and 72% for two-lobe bronchoalveolar lavage, 
Stage 1: sputum induction Stage 2: bronchoalveolar 
lavage
Number of patients recruited 124 35
Number of procedures 200 41
Median age at procedure 8·2 years (4·9–12·6) 8·5 years (6·5–12·6)
Number of procedures in children aged <6 years 72 (36%) ··
Median age (subgroup <6 years) 3·5 years (1·6–4·9) ··
Number of procedures in children aged ≥6 years 128 (64%) ··
Median age (subgroup ≥6 years) 11·1 years (8·2–14·3) ··
Pseudomonas aeruginosa positive (isolated in 
preceding 12 months)
24 (12%) 6 (15%)
Median FEV₁ (where applicable) 89% (76–99) 84% (72–94)
Hypertonic saline naive 37 (19%) 3 (7%)
Wet cough at time of procedure 66 (33%) 14 (34%)
Able to spontaneously expectorate before 
procedure
22 (11%) 2 (5%)
Symptomatic at time of procedure 128 (64%) 32 (82%)
Inpatient procedure 80 (40%) 41 (100%)
Outpatient procedure 120 (60%) 0
Data are n (%) or median (IQR). Denominators for percentages are number of procedures.
Table 1: Patient baseline characteristics
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and for the combination of sputum induction with two-
lobe bronchoalveolar lavage it was 90%. The test-specific 
detection rate for six-lobe bronchoalveolar lavage was 84%, 
and for the combination of sputum induction with six-lobe 
bronchoalveolar lavage it was 98%. These data suggest that 
sputum induction and bronchoalveolar lavage sample 
closely related, but non-identical, lower airway compart-
ments, and that each therefore has an independent con-
tribution in the identification of lower airway pathogens.
To further investigate the sampling ability of sputum 
induction, we extracted total DNA from cough swab, 
sputum induction, and bronchoalveolar lavage samples 
and used RISA profiling to assess the polymicrobial 
signatures from bacterial DNA present in those samples. 
In one illustrative example of RISA profiles of concurrent 
samples by different techniques, the sputum-induction 
polymicrobial signature is directly related to that of 
bronchoalveolar lavage, and discrete from cough swab 
(figure 4A). In another illustrative example, the sputum-
induction polymicrobial signature is a combination of 
contributions from multiple bronchoalveolar lavage 
sample sites, indicating that sputum induction can be 
effective in sampling from a very wide lower airway 
compartment (figure 4B). 
We did not want to discount those pathogens isolated 
by sputum induction alone as false positives, but rather, 
to classify them as additional lower airway pathogens. 
We therefore generated a sensitivity analysis against a 
combined gold standard consisting of all pathogens 
identified by sputum induction and six-lobe broncho-
alveolar lavage. We defined a positive outcome as the 
ability to identify all pathogens in the combined gold 
standard, so the outcome would enable us to quantify the 
ability of any single approach to correctly detect all lower 
airway pathogens in a patient. Sensitivity of sputum 
induction was 0·63 (95% CI 0·42–0·79), sensitivity of 
two-lobe bronchoalveolar lavage was 0·59 (0·39–0·77), 
and sensitivity of six-lobe bronchoalveolar lavage was 
0·81 (0·61–0·93). Sensitivity of combined sputum 
induction and two-lobe bronchoalveolar lavage was 
0·93 (0·74–0·99). The ability of the sputum-induction 
procedure to correctly identify all lower airway pathogens 
in a given patient was not significantly influenced by age 
as a continuous variable (p=0·95) or by whether the 
patient was asymptomatic or symptomatic (p=0·27).
Objective tolerance of the sputum induction procedure 
was good with no significant effects on respiratory rate, 
heart rate, or FEV1% (figure 5). FEV1 increased by more 
than 5% in 21 (23%) of 90 people in whom spirometry 
was done. Subjective tolerance was good. Likert scales 
rated tolerance high, with mean parent or patient scores 
of 8·55 (SD 1·65) and physiotherapist scores 
of 9·09 (1·76).
Children in 27 (14%) of 200 sputum-induction 
procedures had mild side-effects: 17 (9%) became upset, 
of which four (2%) could not complete the procedure; 
six (3%) had mild wheeze, of which two (1%) could not 
complete the procedure; three (2%) patients vomited 
during oropharyngeal suction; one (<1%) became 
transiently dizzy. 108 (96%) of 112 (12 gave no comment)
patients or parents were willing to have regular annual 
sputum-induction procedures.
Discussion
In this interventional trial, we took a systematic approach 
to comprehensively investigate and compare bacterial 
sampling techniques in young children with cystic fibrosis. 
In particular, we tested sputum induction as an infection 
diagnostic technique. We compared pathogen yield from 
sputum induction with concurrent cough swab, single-
lobe bronchoalveolar lavage, two-lobe bronchoalveolar 
lavage, and comprehensive six-lobe bronchoalveolar lavage 
to identify the relative contribution of each approach.
Most patients recruited to both stages of the study were 
unable to spontaneously expectorate before the sputum-
induction procedure irrespective of whether they had a 
wet cough or not. We found the sputum-induction 
procedure to be well tolerated and equally successful in 
all age groups, in the inpatient or outpatient setting, in 
those who were asymptomatic or symptomatic, and in 
children with or without a wet cough.
In stage 1 of this study, sputum induction was compared 
with paired cough swab. Cough swab pathogen positivity 
in this study was equivalent to that reported in similar 
populations in other studies.22 Almost three times as many 
pathogens were identified on sputum induction compared 
with cough swab, and this benefit was reflected to a broadly 
similar degree in all age groups. More pathogens were 
identified on both sputum induction and cough swab in 
children aged 6 years or older, reflecting the greater 
Figure 2: Pathogen yields from concurrent cough swab and sputum induction in 167 paired samples
(A) Total pathogen yield in the whole cohort (n=167) and in subgroups of children younger than 6 years (n=62) 
and those aged 6 years or older (n=105). (B) Specific pathogen yields in the whole cohort (n=167). Bcc=Burkholderia 
cepacia complex. MRSA=meticillin-resistant Staphylococcus aureus. nTM=non-tuberculous Mycobacteria.
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pathogen prevalence in the older age group. The benefits 
of sputum induction over cough swab were seen in 
symptomatic and asymptomatic children, supporting the 
use of sputum induction over cough swab in all situations. 
Sputum induction was positive for a pathogen in 38% of 
paired samples, positive for a pathogen not identified on 
paired cough swab in 31% of cases, and positive for a new 
pathogen not isolated on repeated cough swabs from the 
preceding 12 months in 24% of cases. Sputum induction 
had a considerable effect on patient care, with new 
treatment implemented as a consequence in 31% of cases.
In stage 2 of the study, sputum induction was compared 
with single-lobe, two-lobe, and six-lobe bronchoalveolar 
lavage in a group of children who were largely symptomatic. 
Sequentially higher proportions of pathogens were detected 
by single-lobe, two-lobe, and six-lobe bronchoalveolar 
lavage. The proportion of pathogens isolated by sputum 
induction and two-lobe bronchoalveolar lavage were largely 
equivalent.  Six-lobe bronchoalveolar lavage only identified 
85% of pathogens isolated from all approaches, since some 
important pathogens were uniquely isolated on sputum 
induction.Patient age did not affect the ability for sputum 
induction to correctly describe all lower airway pathogens.
By using multi-approach concurrent sampling from 
upper and lower airways in the same patient, we 
estimated whether pathogens identified by sputum 
induction were upper or lower airway residents. A large 
proportion of pathogens identified by sputum induction 
were identified on bronchoalveolar lavage, confirming 
that sputum induction does effectively sample the lower 
airway. We found that with sequentially wider 
bronchoalveolar lavage sampling, more pathogens that 
were isolated on sputum induction were also identified 
on bronchoalveolar lavage, indicating that sputum 
Cough swab Sputum induction Bronchoalveolar lavage 
sample 1 (RML)
Bronchoalveolar lavage 
sample 2 (LLi)
Bronchoalveolar lavage 
sample 3 (RLL, RUL, LLL, LUL)
5 ·· H influenzae H influenzae H influenzae ··
22* S aureus H influenzae; S aureus; 
P aeruginosa
H influenzae; S aureus H influenzae; S aureus H influenzae; S aureus
45* ·· B cenocepacia ·· ·· ··
57 ·· ·· H influenzae H influenzae H influenzae
60 ·· P aeruginosa ·· ·· ··
70† ·· A xylosoxidans ·· H influenzae H influenzae; A xylosoxidans
73† ·· S aureus S aureus S aureus S aureus; B multivorans
78 ·· P aeruginosa; B multivorans P aeruginosa P aeruginosa; B multivorans P aeruginosa; B multivorans
79 P aeruginosa ·· ·· ·· ··
80† ·· S aureus S aureus S aureus S aureus
86‡ ·· ·· ·· M abscessus ··
91 S aureus; S maltophilia S aureus; S maltophilia S aureus S aureus S aureus; S maltophilia
101† ·· ·· H influenzae; S aureus H influenzae; S aureus H influenzae; S aureus
104† H influenzae; S aureus H influenzae; S aureus; 
B multivorans
H influenzae; S aureus; 
B multivorans
H influenzae; S aureus; 
B multivorans
H influenzae; S aureus; 
B multivorans
107 ·· B cepacia ·· ·· ··
108* ·· S aureus; B multivorans S aureus B multivorans S aureus; B multivorans
115 ·· ·· MRSA MRSA MRSA
121‡ ·· S maltophilia S maltophilia S maltophilia S aureus; S maltophilia
127† ·· ·· ·· S maltophilia S maltophilia
134 ·· MRSA ·· ·· ··
174* P aeruginosa P aeruginosa P aeruginosa P aeruginosa P aeruginosa
178 ·· ·· ·· ·· P aeruginosa
179 S aureus S aureus S aureus S aureus S aureus
184 ·· H influenzae ·· H influenzae H influenzae
196 ·· ·· S aureus S aureus S aureus
208† ·· M abscessus M abscessus ·· ··
209 ·· P aeruginosa P aeruginosa P aeruginosa P aeruginosa
212 ·· H influenzae H influenzae H influenzae H influenzae
Of the 13 contributions that were negative with all sampling techniques (not shown), two were from patients who were asymptomatic. Of the six patients who contributed 
twice, one had no pathogens detected in either contributions. RML=right middle lobe. LLi=left lingular. RLL=right lower lobe. RUL=right upper lobe. LLL=left lower lobe. 
LUL=left upper lobe. MRSA=meticillin-resistant Staphylococcus aureus. *Patients who contributed twice; other contribution was negative. †Patients who were asymptomatic. 
‡One patient contributed twice and had different pathogens detected on the repeat procedure. 
Table 2: Pathogen isolates from the paired cough swab, sputum induction, and bronchoalveolar samples
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induction is capable of sampling very widely from the 
lower airway. Using DNA RISA profiling we showed that 
sputum induction can capture the diversity of bacteria 
associated with multiple bronchoalveolar compartments.
A proportion of pathogens (13%) were identified on 
sputum induction but not on six-lobe bronchoalveolar 
lavage or cough swabs. With the assumption that 
concurrent cough swab and bronchoalveolar lavage 
samples were true negatives,23 this finding suggests that 
sputum induction can identify pathogens from 
compartments of the respiratory tract not sampled by the 
other methods, and raises the question as to where these 
pathogens reside. Bacterial bronchitis is common in 
young children with cystic fibrosis who are symptomatic, 
suggesting the predominant focus of acute infection 
might often be the large intrathoracic airways rather than 
the alveolar bed. The large intrathoracic airways together 
constitute a lower-airway compartment that is most 
easily sampled by the sputum-induction procedure, is 
largely bypassed by even the most extensive approach to 
bronchoalveolar lavage, and is a compartment perhaps 
inadequately considered in the current paradigm of 
lower airway sampling. In this study, sputum induction 
was more successful at isolating the important Gram-
negative pathogens, P aeruginosa and B cepacia complex 
species, compared with concurrent six-lobe lavage 
(figure 3C). This raises the possibility that for some 
pathogens the large intrathoracic airways might be the 
optimal lower airway environment for early infection.
We generated a sensitivity analysis against a combined 
gold standard consisting of all pathogens identified by 
sputum induction and six-lobe bronchoalveolar lavage. 
Sputum induction is shown in these data to be marginally 
more sensitive than the current gold-standard two-lobe 
bronchoalveolar lavage (0·63 vs 0·59). Six-lobe 
bronchoalveolar lavage has a higher sensitivity at 0·81. 
However, sputum induction and two-lobe bronchoalveolar 
Figure 3: Pathogen yield for concurrent cough swab, sputum induction, and single-lobe, two-lobe, and six-lobe BAL in 41 matched samples
(A) Total pathogen yield from each technique. (B) Numbers of unique and overlapping pathogen isolates for the different techniques. (C) Specific pathogen yield. BAL=bronchoalveolar lavage. 
Bcc=Burkholderia cepacia complex. MRSA=meticillin-resistant Staphylococcus aureus. nTM=non-tuberculous Mycobacteria. 
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from concurrent cough swab, sputum induction, and BAL samples
(A) Example 1. (B) Example 2. BAL=bronchoalveolar lavage.
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lavage combined have a sensitivity of 0·93. These data 
highlight independent, sizeable gains in pathogen 
detection from both sputum induction and extended six-
lobe bronchoalveolar lavage, over and above the current 
gold-standard two-lobe bronchoalveolar lavage. This in 
turn questions whether two-lobe bronchoalveolar lavage 
can be considered adequate as a standalone approach to 
understanding lower airway microbiology. We advocate 
from the present data that sputum induction and six-lobe 
lavage should be done together as a new standard of care 
for comprehensive assessment of the lower airway 
pathogen environment in children with cystic fibrosis.
The present data also support sputum induction as a 
non-invasive surrogate for bronchoalveolar lavage. We 
propose that in symptomatic patients, bronchoscopy and 
bronchoalveolar lavage should be reserved for those who 
have not responded to appropriate or empirical antibiotic 
treatment and whose sputum-induction cultures do not 
explain the persistence of symptoms. From our data, a 
successful sputum-induction sample taken before 
bronchoscopy and six-lobe bronchoalveolar lavage 
correctly identified all lower airway pathogens in 63% of 
patients who had one or more pathogen present. The 
routine use of sputum induction followed by appropriate 
treatment for those pathogens isolated could therefore 
substantially reduce the need for bronchoscopy in 
symptomatic patients with cystic fibrosis. This has 
notable implications both for quality of care and cost.
Limitations of the study include the fact that study 
investigators were not blinded to outcome, recruitment 
was not randomised, and some patients contributed on 
more than one occasion. However, the study is likely to 
be representative because 70% of the patients who attend 
the South, West, and Mid-Wales Children’s Cystic 
Fibrosis Service were recruited into this study. We 
adjusted statistical outcomes for repeated measures in 
those patients that were recruited on more than one 
occasion. The bronchoalveolar lavage data apply to a 
cohort of patients who were largely symptomatic, because 
patients were recruited when bronchoscopy was clinically 
indicated. The outcomes of stage 2 of the study therefore 
relate to symptomatic patients and might not be directly 
applicable to surveillance programmes in asymptomatic 
patients with cystic fibrosis.
In conclusion, we have established sputum induction 
as superior to cough swab, and as a credible approach to 
sampling the lower airway in symptomatic children with 
cystic fibrosis. We showed benefit in patients of all ages, 
and in those who are unable to spontaneously expectorate. 
We suggest that the large intrathoracic airways constitute 
an important lower airway compartment that is 
inadequately sampled by standard approaches to 
pathogen surveillance in children with cystic fibrosis. We 
have shown that both sputum induction and six-lobe 
bronchoalveolar lavage contribute important independent 
gains in pathogen detection compared with the current 
gold-standard two-lobe bronchoalveolar lavage, and 
advocate sputum induction and six-lobe bronchoalveolar 
lavage combined as a new standard of care in the 
assessment of the lower airway pathogen environment in 
children with cystic fibrosis. In symptomatic patients, 
doing sputum induction before bronchoalveolar lavage 
will correctly describe the lower airway pathogen 
environment in almost two-thirds of patients, and if used 
routinely, could substantially reduce the number of 
bronchoscopy procedures required. We recommend 
implementation of sputum induction as a regular 
contribution to cystic fibrosis care in children. This 
recommendation is supported by the tolerability of the 
procedure in all age groups, the ease of repeatability, the 
acceptability to parents and patients, the high success of 
obtaining samples, the high proportion of pathogens 
identified, the applicability to both the inpatient and 
outpatient setting, and the clear economic savings 
compared with bronchoscopy.
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Figure 5: Objective assessment of tolerance to the sputum-induction 
procedure in 200 attempted procedures
Before and after procedure measurements of FEV₁ (where applicable), 
respiratory rate, and heart rate.
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